Trials / Recruiting
RecruitingNCT03549416
BioDay Registry: Data Collection Regarding the Use of New Systemic Treatment Options in Patients with Atopic Dermatitis
BioDay Registry: Prospective, Observational Data Collection Regarding the Use of New Systemic Treatment Options in Patients with Atopic Diseases in Daily Practice
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 1,200 (estimated)
- Sponsor
- UMC Utrecht · Academic / Other
- Sex
- All
- Age
- 0 Years
- Healthy volunteers
- Not accepted
Summary
The BioDay Registry aims to address the need for daily practice data regarding the effectiveness and safety of new systemic treatment options (like biologics and Janus kinase inhibitors) in patients with atopic dermatitis and effect on other atopic comorbidities in a multicenter setting. The registry already consists of several additional modules concerning atopic comorbidities, like food allergy and asthma, and a module for conjunctivitis during biologic treatment.
Conditions
Timeline
- Start date
- 2018-01-01
- Primary completion
- 2028-12-31
- Completion
- 2028-12-31
- First posted
- 2018-06-08
- Last updated
- 2025-03-28
Locations
14 sites across 1 country: Netherlands
Source: ClinicalTrials.gov record NCT03549416. Inclusion in this directory is not an endorsement.